Skip to main content
RT @Yuz6Yusof: #ACR21 #Abstr0437 OK, so RTX affects #COVID vaccine but some pts need RTX. Factors predicting response to

Md Yuzaiful Md Yusof Yuz6Yusof

4 years 10 months ago
#ACR21 #Abstr0437 OK, so RTX affects #COVID vaccine but some pts need RTX. Factors predicting response to vaccine: RA vs AAV/IIM Higher IgG Longer time-to-RTX Lower RTX courses Number. Prediction Calculator is developed but need ext. validation #RheumNow https://t.co/iXSaGQ76hS https://t.co/WQAV3GRPBz
RT @Yuz6Yusof: #ACR21 #Abstr0336 ANA is not a great test for #lupus diagnosis. Multianalyte Assay Panel with Cell-Bound

Md Yuzaiful Md Yusof Yuz6Yusof

4 years 10 months ago
#ACR21 #Abstr0336 ANA is not a great test for #lupus diagnosis. Multianalyte Assay Panel with Cell-Bound Complement Activation Products could improve diagnosis (OR 6.3) and Drug Initiation (OR 2.8). Can we speed up implementation to clinic? #RheumNow https://t.co/jLcAtD7FaY https://t.co/YmLwmVWp6k
RT @Yuz6Yusof: #ACR21 #Abstr0261 In stable Non sJIA, is it safe to taper or stop MTX? Of 375 pts in CARRA registry, 24%

Md Yuzaiful Md Yusof Yuz6Yusof

4 years 10 months ago
#ACR21 #Abstr0261 In stable Non sJIA, is it safe to taper or stop MTX? Of 375 pts in CARRA registry, 24% tapered and 14% stopped MTX. No diff in flare rates btw those continued vs tapered/stopped. Sustained remission was in ⬆️tapered vs stopped @RheumNow https://t.co/Mm1yfzRBQz https://t.co/rkHvXWj2oO
RT @Yuz6Yusof: The #Lupus Faculty @RheumNow is proud to share our latest video about learning points from a jam-packed d

Md Yuzaiful Md Yusof Yuz6Yusof

4 years 10 months ago
The #Lupus Faculty @RheumNow is proud to share our latest video about learning points from a jam-packed day at #ACR21 https://t.co/LRyuYyHlhi @KDAO2011 @Janetbirdope @bella_mehta @_Castillo_Pedro
RT @LCalabreseDO: #ACR21 Ignaki Sanz makes the case that +++ AUTOANTIBODIES are integrally involved in #COVID19 immunopa

Leonard Calabrese LCalabreseDO

4 years 10 months ago
#ACR21 Ignaki Sanz makes the case that +++ AUTOANTIBODIES are integrally involved in #COVID19 immunopathogeneisis and may rise and fall w disease states- TBD what role they play in acute disease and #LongCovid @CCalabreseDO @VirusesImmunity @CleClinicMD #COVID19AB https://t.co/9dzCSh5V7R
The arsenal of therapeutics for psoriatic arthritis continues to increase. Risankizumab is an IL-23 inhibitor to the p19 subunit, currently being investigated for treatment of psoriatic arthritis.
Opening Day Report
The opening of ACR2 Convergence was a hit for all who signed up and viewed in. The day included the presidential address by outgoing president Dr. David Karp (UT Southwestern) and a keynote talk and interview with Dr. Seema Yasmin (Stanford). The Year in Review featured a clinical vs basic science Brigham and Women’s Hospital faceoff between its two faculty, Dr. Karen Costenbader and Dr. Michael Brenner.
RT @KDAO2011: "The time for young people is now! You are not the future, you are the present; you can make a difference.

TheDaoIndex KDAO2011

4 years 10 months ago
"The time for young people is now! You are not the future, you are the present; you can make a difference. You may be scared, but take the opportunities and be purposeful." -Dr. A Alakija on the role of young rheumatologists in global health disparities #ACR21 @ACRheum @yodifiji
RT @KDAO2011: Dr. Marvisi presented a case: refractory MPA relapsed w/prednisone < 25 mg/day. Genetic studies c/w VEX

TheDaoIndex KDAO2011

4 years 10 months ago
Dr. Marvisi presented a case: refractory MPA relapsed w/prednisone < 25 mg/day. Genetic studies c/w VEXAS. Is MPA/vasculitis part of VEXAS? The experts say: Maybe- VEXAS is such a new entity, there may be a common pathway (e.g NFkB affected by ubiquination, IL-6 role) #ACR21 https://t.co/kEOsruJ8DE
Appropriate assessment and management of comorbidities and multimorbidity in patients with RA is vital for overall health and well-being of the patient, as well as to encourage treatment adherence, and address social, psychological and quality of life factors. 
RT @KDAO2011: She was considered a "high risk hire" b/c of her accent, being young, and being a mother of 3 children who

TheDaoIndex KDAO2011

4 years 10 months ago
She was considered a "high risk hire" b/c of her accent, being young, and being a mother of 3 children who still needs her. -Dr. Graciela Alarcon, a giant in rheumatology,talked about her life in the Global Women Leaders in Rheumatology #ACR21 @ACRheum @rheumnow #strongwomen https://t.co/Oxmy8ruIZF
RT @KDAO2011: Solutions to the Gender Gap:
👉treat gender equality as an innovation challenge requiring innovative sol

TheDaoIndex KDAO2011

4 years 10 months ago
Solutions to the Gender Gap: 👉treat gender equality as an innovation challenge requiring innovative solutions 👉create culture where people feel personally responsible for change (not coerced) 👉implement action plans to support behavioral changes with measurable targets #ACR21 https://t.co/BrExrHx1S7
RT @KDAO2011: My typo: * patience (but "patients" are needed too for a rheum career)

TheDaoIndex KDAO2011

4 years 10 months ago
My typo: * patience (but "patients" are needed too for a rheum career)
RT @KDAO2011: Drs. Alarcon, Hajjaj-Hassouni, Aggarwal, and March are trailblazers for #WomeninRheum. Sage advice: "The p

TheDaoIndex KDAO2011

4 years 10 months ago
Drs. Alarcon, Hajjaj-Hassouni, Aggarwal, and March are trailblazers for #WomeninRheum. Sage advice: "The people who open doors may be you." "Sometimes, you have to create your own opportunity." "Push your ideas, don't just watch." #ACR21 @acrheum @LauraLewMad11 moderates panel https://t.co/gxmjntDQst
RT @KDAO2011: Dr. P Krause (FDA/CBER Deputy Dir., Office of Vaccine Research and Review) on #COVIDvaccine in kids:
👉C

TheDaoIndex KDAO2011

4 years 10 months ago
Dr. P Krause (FDA/CBER Deputy Dir., Office of Vaccine Research and Review) on #COVIDvaccine in kids: 👉Children respond to vaccine better than adults; can use lower doses 👉the lower dose will mitigate safety concerns (FDA gave EUA for Pfizer vaccine for 5-11 yo) #ACR21 https://t.co/Z7kcYQKZ8S
×